tiprankstipranks
Trending News
More News >
Qyuns Therapeutics Co., Ltd. Class H (HK:2509)
:2509
Hong Kong Market
Advertisement

Qyuns Therapeutics Co., Ltd. Class H (2509) Income Statement

Compare
2 Followers

Qyuns Therapeutics Co., Ltd. Class H Income Statement

Last quarter (Q2 2025), Qyuns Therapeutics Co., Ltd. Class H's total revenue was ¥103.24M, an increase of 359.69% from the same quarter last year. In Q2, Qyuns Therapeutics Co., Ltd. Class H's net income was ¥-14.17M. See Qyuns Therapeutics Co., Ltd. Class H’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 158.79M¥ 14.75M¥ 9.66M¥ 21.35M
Gross Profit
¥ 92.19M¥ 14.75M¥ -25.85M¥ -9.56M
Operating Expenses
¥ 418.56M¥ 504.51M¥ 352.67M¥ 180.71M
Depreciation and Amortization
¥ 30.46M¥ 32.28M¥ 28.65M¥ 23.70M
EBITDA
¥ -311.82M¥ -484.12M¥ -295.51M¥ -155.65M
Operating Income
¥ -326.37M¥ -504.51M¥ -293.69M¥ -168.62M
Other Income/Expenses
¥ -23.39M¥ -16.82M¥ -18.69M¥ -257.92M
Pretax Income
¥ -349.76M¥ -521.33M¥ -312.38M¥ -426.54M
Net Income
¥ -335.57M¥ -507.75M¥ -298.19M¥ -411.04M
Per Share Metrics
Basic EPS
¥ -1.53¥ -2.47¥ -1.56¥ -1.62
Diluted EPS
¥ -1.53¥ -2.47¥ -1.56¥ -1.62
Weighted Average Shares Outstanding
219.44M 205.67M 222.07M 222.07M
Weighted Average Shares Outstanding (Diluted)
219.44M 205.67M 222.07M 222.07M
Currency in CNY

Qyuns Therapeutics Co., Ltd. Class H Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis